Olaparib 763113-22-0 EON
2 Inquiries
763113-22-0
Pharmaceutical Grade
98%
According to client requirements
2026-06-30
Nootropics,Sarms,Peptides,API,Intermediates
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionBasic Info
-
Product Name:
Olaparib
Other Name:1(2H)-Phthalazinone,4-[[3-[[4-(cyclopropylcarbonyl)-1-piperazinyl]carbonyl]-4-fluorophenyl]methyl]-;Piperazine,1-(cyclopropylcarbonyl)-4-[5-[(3,4-dihydro-4-oxo-1-phthalazinyl)methyl]-2-fluorobenzoyl]-;4-[[3-[[4-(Cyclopropylcarbonyl)-1-piperazinyl]carbonyl]-4-fluorophenyl]methyl]-1(2H)-phthalazinone;Olaparib;KU 59436;AZD 2281;KU 0059436;4-(3-(4-(Cyclopropanecarbonyl)piperazine-1-carbonyl)-4-fluorobenzyl)phthalazin-1(2H)-one;Lynparza;AZD2281;AZD-2281;937799-91-2;1021843-02-6;894104-70-2
CAS No.:763113-22-0
Molecular Formula:C24H23FN4O3
InChIKeys:InChIKey=FDLYAMZZIXQODN-UHFFFAOYSA-N
Molecular Weight:434.469
Exact Mass:434.46
EC Number:1308068-626-2
UNII:WOH1JD9AR8
NSC Number:747856
NCI Thesaurus Code:C71721
ATC Code:L01XX46|L - Antineoplastic and immunomodulating agents
HScode:29339900
Categories:
Characteristics-
PSA:
82.1
XLogP3:1.9
Density:1.4±0.1 g/cm3
Refractive Index:1.702
Hazard IdentificationClassification of the substance or mixture
Acute toxicity - Category 3, Oral
Reproductive toxicity, Category 1B
Specific target organ toxicity â repeated exposure, Category 1
GHS label elements, including precautionary statements
Pictogram(s) 
Signal word Danger
Hazard statement(s) H301 Toxic if swallowed
H360 May damage fertility or the unborn child
H372 Causes damage to organs through prolonged or repeated exposure
Precautionary statement(s) Prevention P264 Wash ... thoroughly after handling.
P270 Do not eat, drink or smoke when using this product.
P203 Obtain, read and follow all safety instructions before use.
P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...
P260 Do not breathe dust/fume/gas/mist/vapours/spray.
Response P301+P316 IF SWALLOWED: Get emergency medical help immediately.
P321 Specific treatment (see ... on this label).
P330 Rinse mouth.
P318 IF exposed or concerned, get medical advice.
P319 Get medical help if you feel unwell.
Storage P405 Store locked up.
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Nootropics,Sarms,Peptides,API,Intermediates
-
Location:
Kemp House, 160 City Road London, EC1V 2NX
-
Payment Terms:
TT against copy of documents,100% TT in advance
-
Average lead Time:
2
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
Less than 5
-
Year of Establishment:
2021
-
-
Inquiry History2 Inquiries
Country Product Purchase Quantity Date Posted 
India
OLAPARIB (FORM A)
5 G Nov 4, 2025
India
Olaparib
2 G Jan 9, 2024 Post an enquiry for this product